Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Files An 8-K Regulation FD Disclosure
Item7.01.Regulation FD Disclosure.
Commencing January 9, 2017, Titan Pharmaceuticals, Inc. will
present and post on its website an updated corporate
presentation, a copy of which is attached hereto as Exhibit 99.1
and incorporated herein by reference.
The foregoing information, including the presentation attached
hereto as an exhibit, is being furnished to Item 7.01 of this
Current Report and shall not be deemed filed for the purposes of
Section 18 of the Securities and Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section.
This information shall not be incorporated by reference into any
registration statement to the Securities Act of 1933, as amended.
Item9.01. Financial Statement and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Corporate Presentation |
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Recent Trading Information
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) closed its last trading session at with 50,488 shares trading hands.
